Logo

AstraZeneca

Saga Diagnostics, AstraZeneca Ink Digital PCR Assay Development Deal

Lund, Sweden-based Saga will develop assays using its SagaSafe digital PCR technology for undisclosed methylated targets in both blood and tissue. 

UK Biobank WGS Consortium Describes 150K Genome Dataset at ASHG, Sets Sights on 500K
Premium

Researchers described the variant, disease, drug target, and drug safety insights being gained analyzing more than 150,000 UK Biobank whole-genome sequences.

Genomenon, Alexion Pharmaceuticals Team on Rare Disease Dx

Genomenon will apply its AI-driven technology to develop a "genomic landscape" for specific conditions and combine those data with therapy and trial information.

Thermo Fisher Scientific, AstraZeneca Team up to Develop CDx for Targeted Drugs

The next-generation sequencing based companion diagnostics will be paired with targeted therapies that are being developed for several diseases.

New Research Consortium to Standardize Single-Cell Sequencing for Cancer Drug Resistance Studies

The main goal of the Persist-Seq private-public consortium is to generate a large single-cell cancer database in order to enable research on drug resistance.

Jun 14, 2021

Genecast to Evaluate Liquid Biopsy EGFR Mutation Test in Early-Stage Non-Small Cell Lung Cancer

Jun 7, 2021

Lynparza Benefit in Early BRCA-Mutated Breast Cancer Reignites Universal Genetic Testing Discussion
Premium

Jun 4, 2021

Akoya Biosciences, AstraZeneca Collaborate on Spatial Biomarker Profiling for Immuno-Oncology

Feb 25, 2021

Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch
Premium

Feb 19, 2021

AmoyDx, AstraZeneca Strike Ovarian Cancer Companion Diagnostic Alliance

Jan 11, 2021

Adaptive Biotechnologies, AstraZeneca Collaborate on Mapping Immune Response in Cancer

Jan 11, 2021

Grail Inks Deals With Amgen, AstraZeneca, Bristol Myers Squibb for MRD Test Development

Dec 16, 2020

Rare Genetic Variants Can Contribute to Ischemic Heart Failure

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Dec 7, 2020

UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects

Nov 9, 2020

FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Lynparza

Oct 29, 2020

Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC

Sep 14, 2020

Thermo Fisher Scientific, AstraZeneca, U of Nebraska Partner for Protein Biomarker Discovery

Aug 21, 2020

RenalytixAI, AstraZeneca Ink Agreement to Enhance Chronic Disease Patient Outcomes

Jun 4, 2020

Tumor Mutational Burden in Blood May Predict Immunotherapy Response in Head, Neck Cancer

May 26, 2020

AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials

May 21, 2020

Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab
Premium

May 20, 2020

FDA Approves Lynparza With Myriad, Foundation Med CDx Tests in HRR-Mutated Prostate Cancer

May 11, 2020

FDA Approves Lynparza/Avastin With Myriad Genetics CDx for Platinum-Sensitive Ovarian Cancer

Apr 8, 2020

Novacyt, AstraZeneca, GSK, University of Cambridge Partner to Increase SARS-CoV-2 Testing in UK

Breaking News
The Scan

Omicron's Sewage Path

The New York Times writes that testing sewage is helping public health officials track Omicron.

IBM Sells Part of Watson Health

The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm.

Identifying the Right Whales

The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought.

Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer

In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.